Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of its CTech™ SoloVPE ® PLUS System, the …

The innovative bioprocessing products manufactured by Repligen are designed to address these important needs of biopharmaceutical manufacturers in an increasingly competitive environment.

At Repligen, we provide opportunities for conversation about DEI, offer DEI education resources, encourage allyship, and invest time and energy into developing diverse talent.

Whether you are in fed-batch, hybrid continuous or full continuous mode, or working with therapeutic proteins, gene therapy or vaccines, you can use leading edge solutions from Repligen to streamline …

Dec 16, 2025 · Investor Relations About Repligen We are a US-based, global developer and manufacturer of highly innovative bioprocessing tools and technologies. We provide advanced …

Locations About Repligen Leadership Careers News Room Investors Sustainability Contact Repligen Corporation Headquarters

Repligen is a leader in Tangential Flow Filtration technologies, offering systems that combine cutting-edge innovation, reliable performance, and flexible scalability.

Jan 6, 2026 · Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of …

Explore Repligen's comprehensive document search tool for easy access to quality and compliance documents, including certificates of analysis, conformance, and other essential quality-related …